Home › Forums › Investments in the US › Summary of CNBC “Mad Money” Episodes › Mad Money: Key points from September 24, 2020 (Thursday) episode
- This topic is empty.
-
AuthorPosts
-
-
2020-09-24 at 11:18 PM #2719
Jun Kurema (暮眞★潤)
KeymasterSummary of CNBC program “Mad Money w/ Jim Cramer” which was on air on Thursday, September 24, 2020. Links to CNBC sites which contain video clips and transcripts are also listed.
Olive Garden-parent Darden is ‘more attractive’ the longer the pandemic drags, Jim Cramer says (https://www.cnbc.com/2020/09/24/jim-cramer-says-olive-garden-parent-darden-is-a-buy-during-pandemic.html)
- “Mad Money” host Jim Cramer told investors to buy shares of Olive Garden-parent Darden due to the uncertainty around the coronavirus.
- “All I know is the stock deserves to go higher, and the longer the pandemic goes on, the more attractive it gets,” he said Thursday.
- “Unfortunately, without some help from Congress, you better believe most independent restaurants will not be able to hold out,” Cramer said.
Ticker: DRI
Jim Cramer says Nvidia is a buy here, cites ‘unstoppable’ potential of Arm acquisition (https://www.cnbc.com/2020/09/24/jim-cramer-says-nvidia-is-a-buy-here-cites-unstoppable-potential-of-arm-acquisition.html)
- “If Nvidia can close on Arm Holdings, the stock’s gonna be unstoppable even after its magnificent multiyear run,” CNBC’s Jim Cramer said.
- The “Mad Money” host noted there are significant regulatory roadblocks ahead but said he believes the acquisition will ultimately go through.
- “Put them both together, and you’ve got the undisputed king of the semiconductor industry,” he said.
Ticker: NVDA
Executive Interview: Sanofi isn’t cutting corners in coronavirus vaccine development despite acceleration, CEO says (https://www.cnbc.com/2020/09/24/-sanofi-ceo-paul-hudson-on-coroanvirus-vaccine-development-timeline.html)
- “We haven’t changed anything in the way we do things, we’ve just accelerated,” Sanofi CEO Paul Hudson told CNBC’s Jim Cramer.
- Hudson expressed confidence in the company’s coronavirus vaccine candidates, noting it produces about a billion doses of other vaccines each other.
- “We feel pressure to get it right and maintain the standards and to play a big part in helping people get back to normal,” Hudson added on “Mad Money.”
Ticker: SNY
Jim Cramer says Abbott Labs’ rapid coronavirus test can boost the economy and stock market (https://www.cnbc.com/video/2020/09/24/cramer-abbott-labs-rapid-coronavirus-test-can-boost-economy-stocks.html)
“Mad Money” host Jim Cramer said the rapid coronavirus test from Abbott Labs could help the U.S. resume more in-person activities safely, most importantly school, and boost the economy and stocks as a result.
Ticker: ABT
Cramer’s lightning round: BioXcel Therapeutics is good for a spec play (https://www.cnbc.com/2020/09/24/cramer-lightning-round-bioxcel-therapeutics-is-a-good-spec-play.html)
- BioXcel Therapeutics: “It’s got all the great buzz words. It’s biopharma, it’s artificial intelligence, and the reason why I’m going to say that it’s OK is because it can be your own speculation. I’m willing everyone to have everyone have one speculation. That can be yours.”
- Schrodinger: “No, I have not liked this company. I don’t really get the attraction to it. … It’s just not a great company. … They can come on and tell me otherwise.”
- Dada Nexus: “I am recommending Alibaba. I’m actually saying buy Alibaba aggressively, but that’s about all I want to do with China. I mean, I think JD’s pretty good too, but that’s enough for me in the midst of a trade war.”
- HCA Healthcare: “There has just been tremendous turmoil. It’s very expensive to run a hospital right now and they’re not going to get any breaks, I think, from either party. So, I don’t want to yet as you go into the election.”
- ADT: “I don’t like that company. I don’t think it’s run very well. I think there’s a lot of other companies offering those services.”
- Five9: “It is the best contact call center. We’ve had them on a number of times. Everytime I’m impressed. Everytime I know that they do tremendous value. I can’t believe that they’re actually not taken over by someone because it does work with a lot of other comapnies that need contact cloud centers.”
Ticker: BTAI, SDGR, DADA, BABA, JD, HCA, ADT, FIVN
Other Topics (no video clip): Am I diversified?
Other topics discussed — Goldman Sachs (GS) [buy], Carnival (CCL) [not recommend cruise line now. If you want to buy, Norwegian is better], Humana (HUM) [I don’t want to own]
If you have any questions or comments on this topic, please start a new topic using its parent forum “Investments in the US”.
****************************
Previous Episode Next Episode
-
-
AuthorPosts
- The topic ‘Mad Money: Key points from September 24, 2020 (Thursday) episode’ is closed to new replies.